Target intelligence / Profile preview

Alpha-like protein 3 (Alp3) (Alp3)

Target
Alp3
Molecular classification
Bacterial surface protein, Adhesin, Invasin, Alpha-like protein family
01

Overview

Alpha-like protein 3 (Alp3) is a surface-anchored protein belonging to the alpha-like protein (Alp) family of Streptococcus agalactiae (Group B Streptococcus, GBS). It is a chimeric molecule characterized by a mosaic structure of repetitive domains shared with other family members such as Alpha C and Rib. Alp3 is a key virulence factor that facilitates bacterial adherence to and invasion of host epithelial cells, particularly within the vaginal and cervical mucosa, which is critical for maternal colonization and subsequent neonatal infection. It is also expressed by Streptococcus pyogenes (Group A Streptococcus), where it is commonly referred to as R28. As a highly immunogenic surface antigen, Alp3 is a major target in the development of maternal vaccines designed to provide passive immunity to newborns against GBS-induced sepsis, meningitis, and pneumonia.

Other names
R28Protein R28Alp3 proteinSurface protein Alp3
02

Mechanism of action

Induction of protective opsonophagocytic antibodies that prevent bacterial adherence and promote immune clearance.

03

Biological functions

Bacterial adherenceHost cell invasionVirulence factorImmune evasion
04

Disease associations

Group B Streptococcal infectionNeonatal sepsisMeningitisPneumoniaGroup A Streptococcal infection
05

Safety considerations

Antigenic variationImmune escapeCross-reactivity with other Alp proteins
06

Interacting drugs

GBS-NN vaccine

1 more in the full profile.

07

Biomarkers

Alp3 surface expressionalp3 gene presence

Beyond the preview

Go deeper on Alpha-like protein 3 (Alp3) (Alp3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-like protein 3 (Alp3) (Alp3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call